Egliton 3 Injection 1's
₹360*
MRP ₹400
10% off
₹340*
MRP ₹400
15% CB
₹60 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Egliton 3 Injection 1's is an anti-cancer medicine used in the treatment of hairy cell leukaemia, follicular leukaemia, malignant leukaemia, AIDS-Related Kaposi’s Sarcoma, Hodgkin’s Lymphoma in combination with anthracycline-containing chemotherapy medicine, chronic hepatitis B and C. Cancer is a disease where the cells grow abnormally and divide uncontrollably. It can also be used when the cancer has spread to other parts of the body.
Egliton 3 Injection 1's contains Interferon alpha 2b as an active ingredient, which belongs to the class of immunomodulators. It works by inhibiting the abnormal growth of cancer cells. It also helps reduce the amount of hepatitis C virus (HCV) in the body.
Egliton 3 Injection 1's may cause certain side effects such as flu-like symptoms, diarrhoea, fatigue, nausea, headache, dizziness, vomiting, tiredness, and injection site reactions. If the side effects persist or bother you, consult your doctor. Egliton 3 Injection 1's will be administered by a trained doctor. Hence, do not self-administer.
Avoid taking it and inform your doctor if you are allergic to Egliton 3 Injection 1's or its components. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, autoimmune hepatitis, a history of autoimmune disease, or HIV infection, as it can cause adverse effects. $ is not recommended for use in pregnancy as it is known to cause fetal harm. Breastfeeding should be avoided when on treatment with Egliton 3 Injection 1's.
Egliton 3 Injection 1's contains Interferon alpha 2B, which is used for treating patients with different types of cancer. This medicine works by inhibiting the abnormal growth of cancer cells. It also helps reduce the amount of hepatitis C virus (HCV) in the body.
Egliton 3 Injection 1's should be avoided if you are allergic to it or any other components of this medicine. Before taking Egliton 3 Injection 1's, inform your doctor if you have any cardiovascular conditions, liver/kidney disease, autoimmune hepatitis, a history of autoimmune disease, or HIV infection, as it can cause adverse effects.. Egliton 3 Injection 1's may cause fetal harm. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Breastfeeding should be discontinued in nursing mothers during the treatment. Egliton 3 Injection 1's is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions: Egliton 3 Injection 1's may interact with monoclonal antibodies (etanercept, golimumab, infliximab, natalizumab, abciximab), antiviral drugs (indinavir, efavirenz, atazanavir), anticoagulants (apixaban, dicumarol), etc.
Drug-Food Interactions: No interaction found.
Drug-Disease Interactions: Inform your doctor if you have cardiac problems, lung disease, liver/kidney disease or allergic reactions.
Malignant Melanoma: Melanoma is a type of skin cancer in which the cancer cells grow in melanocytes. It is mainly caused by harmful UV radiation from the sun. Malignant melanoma is common in fair-skinned and freckled individuals. It results in mole formation, typically on the skin of the face.
Hepatitis C Virus Infection: It is a contagious infection caused by the hepatitis C virus affecting the liver. This infection spreads from person to person through blood contact (being pricked with a contaminated needle or using a razor), intimate contact with the infected person, direct contact with infected blood, or contact with any other personal items with leftovers of infected fluid or even from mother to baby during birth. The symptoms may not appear immediately. Some may take between 2 to 12 weeks to appear. Few people may have mild to moderate symptoms such as dark urine, loss of appetite, fever, joint pain, or stomach discomfort. The complications of untreated chronic hepatitis C include liver cancer or liver cirrhosis (scarring).
Hepatitis B Virus Infection: It is a serious contagious infection caused by the Hepatitis B virus affecting the liver. It can be an acute (an infected person may be sick for only a few days) or chronic infection (it develops slowly but progresses to a serious lifelong infection). This infection spreads from person to person through blood contact (being pricked with a contaminated needle, using a razor), intimate contact with the infected person, direct contact with infected blood, or contact with any other personal items with leftovers of infected fluid or even from mother to baby during birth. Egliton 3 Injection 1's is used to treat HBV infection.
Follicular lymphoma: It is a type of non-Hodgkins lymphoma with slow-growing (chronic) cancer with abnormal growth of B lymphocytes, a type of white blood cells that help fight infection. This results in the buildup of too many B lymphocytes in the blood, lymph nodes, bone marrow, and spleen.
Hairy cell leukemia: It is a rare type of cancer that occurs in the bone marrow and blood. It increases the number of lymphocytes (a type of white blood cell). The symptoms include fever, enlarged liver, bone or joint pain, shortness of breath, weakness, and bleeding from gums or bruises.
Country of origin
Keep Refrigerated. Do not freeze.Prepaid payment required.
Alcohol
Caution
It is unknown whether Egliton 3 Injection 1's interacts with alcohol. Consult your doctor for more information.
Pregnancy
Unsafe
Egliton 3 Injection 1's is not recommended for use in pregnancy as it may cause fetal toxicity and harm your foetus. Hence, if you are pregnant or planning to be pregnant, inform your doctor before receiving Egliton 3 Injection 1's.
Breast Feeding
Unsafe
Egliton 3 Injection 1's should not be taken if you are breastfeeding, as it passes into breast milk and may harm your infant. Avoid nursing your child while on treatment with this medicine.
Driving
Not applicable
Egliton 3 Injection 1's will be administered to hospitalized patients. Driving is not recommended.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Egliton 3 Injection 1's. Egliton 3 Injection 1's may cause liver impairment. Hence, inform your doctor if you observe any symptoms such as jaundice, dark-coloured urine, or nausea. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Kidney
Caution
Limited data are available on the effect of Egliton 3 Injection 1's in kidney-impaired patients. If you have a pre-existing or a history of kidney disease, inform your doctor.
Children
Unsafe
Egliton 3 Injection 1's is not recommended for use in children below 18 years as the safety and efficacy are not established.
Product Substitutes
We provide you with authentic, trustworthy and relevant information